Novanta (NOVT) Set to Announce Quarterly Earnings on Tuesday

Novanta (NASDAQ:NOVT) will post its quarterly earnings results before the market opens on Tuesday, May 7th. Analysts expect Novanta to post earnings of $0.57 per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Novanta (NASDAQ:NOVT) last announced its quarterly earnings data on Wednesday, February 28th. The technology company reported $0.63 EPS for the quarter, meeting the consensus estimate of $0.63. The company had revenue of $211.60 million for the quarter, compared to the consensus estimate of $210.90 million. Novanta had a net margin of 8.27% and a return on equity of 17.15%. Novanta’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.75 EPS. On average, analysts expect Novanta to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Novanta Trading Up 0.2 %

Shares of NASDAQ NOVT opened at $159.89 on Monday. The firm’s 50 day moving average price is $166.82 and its 200-day moving average price is $157.06. Novanta has a 52-week low of $111.20 and a 52-week high of $187.60. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.91 and a current ratio of 2.98. The company has a market cap of $5.73 billion, a PE ratio of 78.76 and a beta of 1.35.

Insider Buying and Selling

In other Novanta news, CEO Matthijs Glastra sold 5,000 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $172.00, for a total transaction of $860,000.00. Following the sale, the chief executive officer now directly owns 24,572 shares in the company, valued at approximately $4,226,384. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, CFO Robert Buckley sold 3,000 shares of the stock in a transaction that occurred on Thursday, February 29th. The shares were sold at an average price of $170.40, for a total transaction of $511,200.00. Following the transaction, the chief financial officer now owns 120,419 shares in the company, valued at $20,519,397.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Matthijs Glastra sold 5,000 shares of Novanta stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $172.00, for a total transaction of $860,000.00. Following the completion of the sale, the chief executive officer now directly owns 24,572 shares of the company’s stock, valued at approximately $4,226,384. The disclosure for this sale can be found here. Insiders sold a total of 9,500 shares of company stock worth $1,611,545 in the last three months. Insiders own 1.20% of the company’s stock.

Novanta Company Profile

Novanta Inc, together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.